Radiation Oncology/Therapy

Elekta secures U.S. FDA 510(k) clearance for Evo

By AuntMinnie.com staff writers

The company is moving forward with Elekta Evo CT-Linac.

January 16, 2026

Alliance for Clinical Trials in Oncology launches prostate cancer trial

By AuntMinnie.com staff writers

The phase III trial, called RECIPROCAL, will include 1,500 patients with metastatic, castration-resistant prostate cancer.

January 5, 2026

What are Pluvicto discontinuation rates in a real-world setting?

By Will Morton

There is a critical need to predict nonresponders and potential discontinuers prior to treatment.

January 5, 2026

ASTRO introduces new research foundation approach

By AuntMinnie.com staff writers

ASTRO is renaming its research foundation and highlighting new aims for the institute to go along with the update.

January 2, 2026

Proton therapy effective for patients with oropharyngeal cancer

By Will Morton

The treatment targets tumors with charged particles rather than the high-energy x-rays of photon therapy.

December 15, 2025

Lunit, Daiichi Sankyo to partner on AI biomarker, oncology research

By AuntMinnie.com staff writers

Under the collaboration, Daiichi Sankyo will make use of Lunit's SCOPE uIHC and SCOPE IO.

December 15, 2025

Telix and Varian enter research collaboration

By AuntMinnie.com staff writers

The two firms will identify opportunities to use Telix’s prostate cancer PET imaging agents in selecting patients for radiation therapy.

December 10, 2025

GE HealthCare inks RT, AI partnerships

By AuntMinnie.com staff writers

GE HealthCare announced two key collaborations for its existing and new imaging technology at RSNA 2025.

December 5, 2025

ASTRO issues guidance on radiation therapy for stomach cancer

By AuntMinnie.com staff writers

The recommendations are based on a systematic review of research published from 2001 through mid-2025.

November 19, 2025

Partial breast irradiation effective in women with HR+ cancers

By Amerigo Allegretto

Stereotactic partial breast irradiation can lead to higher rates of pathological complete response in women with HR+ cancers.

November 14, 2025

GT Medical releases interim data for GammaTile trial

By AuntMinnie.com staff writers

The interim findings showed superior efficacy for GammaTile with a safety profile comparable to the standard of care.

October 21, 2025

Pluvicto reduces progression of advanced prostate cancer

By AuntMinnie.com staff writers

New study findings were presented October 19 at the European Society for Medical Oncology 2025 annual meeting in Berlin.

October 20, 2025

Page 1 of 468

Next Page